Stealth Therapeutics, Inc. — Form D
Stealth Therapeutics, Inc. of MADISON, WI, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-10. The offering totals $200K, of which $140K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-10
- Form: D
- Accession: 0000892712-17-000603
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $140K
- Remaining: $60K
- Investors: 5
- Date of first sale: 2017-08-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-292547
Issuer
- Name: Stealth Therapeutics, Inc.
- CIK: 0001544817
- Entity type: Corporation
- Jurisdiction: WISCONSIN
- Incorporated: 2007
- Address: 101 NOB HILL ROAD, MADISON, WI, 53713
- Phone: 608-217-2685
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Bradley Glenn | Director | Madison, WI |
| Kenneth U Johnson | Director | Stoughton, WI |
| Jake U Orville | Director | Madison, WI |
| George U Trutza | Director | Madison, WI |
| Sam Adam | Executive Officer | Madison, WI |
| Sam Adams | Executive Officer | Madison, WI |
| George Trutzka | Director | Madison, WI |
| Jake Orville | Director | Madison, WI |
| Peter Drumm | Executive Officer | Madison, WI |
Other filings by this issuer (3)
More